Citations

Showing 10 of 108135 citations.

Psychological Burden of the COVID-19 Pandemic – the Voice of the Young Doctors’ Generation: an International Survey.
Czerwińska, Katarzyna , Beneria, Anna , Bañeras, Jordi , Kwasiborski, Przemysław , Velagapudi, Poonam , Ijioma, Nkechinyere , Fekadu, Chala, Vandenbriele, Christophe , Garaygordobil, Diego Araiza , Wood, Alice M., Johnson, Victoria E. , Aleksić, Milica , Pazderník, Michal , Rosenberg, Alex , Ijioma, Nkechi , Vandenbriele, Christophe , Trêpa, Maria , Stratinaki, M , Tun, Han Naung , Verdoia, Monica , Moscatelli, Sara , Shchendrygina, Anastasia , Wood, Alice, Johnson, Victoria, Reinstadler, Sebastian J. , Aleksic, Milica

Mayo Clinic

No container title available | September 1, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-856227/v1 Get It

Abstract Background: Young doctors have made up a substantial part of healthcare forces during the Coronavirus Disease 2019 (COVID-19) pandemic. The aim of this study was to determine the rate and level of psychological distress among young doctors during the COVID-19 outbreak. Methods: This cross-sectional cohort study, dedicated to doctors, at or below the age of 40, was conducted in 62 countries as an online survey between September – November 2020. Survey questions covered the following areas: 1. demographics 2. work environment 3.the ‘Hospital Anxiety and Depression Scale (HADS)’ and the ‘Perceived Stress Scale 10 (PSS-10)’. The primary outcome was the rate and level of anxiety/depression and stress among surveyed population defined according to adopted cut off values (HADS>13, PSS-10>14). Secondary outcomes included risk factors for increased HADS and PSS-10 scores.Results: Among 1186 respondents, median aged 32 [29–36], 675 (44.5%) females, 96% reported a high level of anxiety/depression and 97% reported a high level of stress. Factors associated with significantly higher scores for anxiety/depression were increased work hours [OR 1.61 95%CI (1.12–2.34);p=0.01] and loss of pay [OR 5.53, 95% CI (1.57–19.47);p=0.008], while reduced work hours [OR 0.68 95% CI (0.48 - 0.98);p=0.03], increased salaries [OR 0.54 95% CI (0.35–0.85);p=0.003) and good training [OR 0.99 95%CI (0.99– 1.00);p=0.002] were associated with lower scores. Higher scores for stress were associated with higher professional experience [OR 1.08 95% CI (1.02–1.14);p=0.008], reduced salaries [OR 1.74 95% CI (1.01–2.92);p=0.04] and living with a partner [OR 1.53 95% CI (1.08–2.17);p=0.01]. Conclusions: A high rate of young doctors working clinically during the COVID-19 pandemic reported a persistently high level of psychological distress more than six months after the initial outbreak. Improvements in work organization, including reduced work hours and financial security are essential to prevent further psychological suffering among young doctors worldwide.
Sociodemographic, Clinical, and Treatment-Related Factors Associated With Hyperglycemic Crises Among Adults With Type 1 or Type 2 Diabetes in the US From 2014 to 2020
Galindo, Rodolfo J. , Swarna, Kavya, Houten, Holly K. Van , Shah, Nilay D. , Galindo, Rodolfo J , McCoy, Rozalina G. , O’Connor, Patrick J. , Umpierrez, Guillermo E.

Mayo Clinic

JAMA Network Open | September 1, 2021 | Volume: 4 | Issue: 9 | Pages: e2123471

10.1001/jamanetworkopen.2021.23471 | PMID 34468753 Get It

Hospital transfusion service operations during the SARS‐CoV‐2 pandemic: Lessons learned from the AABB hospital survey in preparation for the next infectious disease outbreak
Rajbhandary, Srijana , Shmookler, Aaron , Cohn, Claudia S. , Nunes, Eduardo, Karafin, Matthew S. , Stubbs, James R. , Pagano, Monica B. , Stubbs, James R , Cohn, Claudia S , Pagano, Monica B

Mayo Clinic

Transfusion | September 1, 2021 | Volume: 61 | Issue: 11 | Pages: 3129-3138

10.1111/trf.16643 | PMID 34469010 Get It

AbstractBackgroundThe SARS‐CoV‐2 pandemic disrupted hospital operations, affected the blood supply, and challenged the health care system to develop new therapeutic options, including convalescent plasma (CCP). The aim of this study is to describe and analyze blood supply fluctuations and the use of convalescent plasma in 2020.MethodsAABB distributed a weekly and biweekly questionnaire through email to hospital‐based members (HBM).ResultsThe survey was sent to 887 HBM with 479 unique respondents, most of the hospitals served pediatric and adult patients, and all states of the country participated, except Idaho and Vermont. Fifty four percent of HBM reported increased wastage in the early phase of the pandemic (May), which decreased to 4% by the end of June and throughout the rest of the year. The majority of HBM reported receiving alerts from their blood suppliers reporting blood shortages throughout the year. During March and April, only 12% of HBM were performing elective surgical procedures. The top reasons to delay procedures were: bed availability (28%); COVID‐19 caseload (23%; and blood availability (19%). By mid‐April, 42% HBM had transfused CCP and reported >24 h delay in getting the units; the vast majority obtained CCP using the Expanded Access Protocol, and later, the Emergency Use Authorization. HBM consistently prioritized the most severe patients to receive CCP, but the proportion of severely ill recipients fell from 52% to 37% between May and October, with an increase from 5% to 21% of HBM providing CCP transfusion early in the course of the disease.DiscussionBlood utilization and availability fluctuated during the pandemic. The fluctuations appeared to be related to the number of COVID‐19 in the community. The use and regulatory landscape of CCP rapidly evolved over the first 8 months of the pandemic.
Classification of Distinct Patterns of Ischemic Cholangiopathy Following DCD Liver Transplantation: Distinct Clinical Courses and Long-term Outcomes From a Multicenter Cohort
Croome, Kristopher P. , Mathur, Amit K. , Aqel, Bashar , Yang, Liu , Taner, Timuçin , Rosen, Charles B. , Paz‐Fumagalli, Ricardo , Paz-Fumagalli, Ricardo, Taner, C. Burcin , Croome, Kris P , Aqel, Bashar A. , Heimbach, Julie K. , Yang, Liu

Mayo Clinic

Transplantation | September 1, 2021 | Volume: 106 | Issue: 6 | Pages: 1206-1214

10.1097/tp.0000000000003928 | PMID 34468429 Get It

Background. As the number of donation after circulatory death (DCD) liver transplants (LTs) performed in the United States continues to increase annually, there has been interest by policy makers to develop a more robust exception point safety net for patients who develop ischemic cholangiopathy (IC) following DCD LT. As such, there is a need for better understanding of the clinical course and long-term outcomes in patients who develop IC, as well as determining if IC can be classified into distinct categories with distinctly different clinical outcomes. Methods. All DCD LT performed at Mayo Clinic Florida, Mayo Clinic Arizona, and Mayo Clinic Rochester from January 1999 to March 2020 were included (N = 770). Outcomes were compared between 4 distinct radiologic patterns of IC: diffuse necrosis, multifocal progressive, confluence dominant, and minor form. Results. In total, 88 (11.4%) patients developed IC, of which 42 (5.5%) were listed for retransplantation of liver (ReLT). Patients with diffuse necrosis and multifocal progressive patterns suffered from frequent hospital admissions for cholangitis in the first year following DCD LT (median 3 and 2), were largely stent dependent (100% and 85.7%), and almost universally required ReLT. Patients with confluence dominant disease were managed with multiple stents and frequently recovered, ultimately becoming stent free without need for ReLT. Patients with the minor form IC did well with limited need for stent placement or repeat procedures and did not require ReLT. Graft survival was different between the 4 distinct IC patterns ( P < 0.001). Conclusions. The present analysis provides a detailed analysis on the natural history and clinical course of IC. Patients developing IC can be classified into 4 distinct patterns with distinct clinical courses.
Three Adjacent Temporal Defects
Rorex, Jennifer N. , Fathizadeh, Sam, Fathi, Ramin, Fathizadeh, Sam

Mayo Clinic

Dermatologic Surgery | September 1, 2021 | Volume: 48 | Issue: 10 | Pages: 1101-1103

10.1097/dss.0000000000003226 | PMID 34468412 Get It

Rates of Upstaging, Between Diagnosis and Surgery, and Clinical Management of Metastatic Cutaneous Squamous Cell Carcinoma: A Case–Control Study
Costello, Collin M., Cumsky, Helen J. L., Severson, Kevin J., Mi, Lanyu, DiCaudo, David J., Ochoa, Shari A., Baum, Christian L., Mangold, Aaron R., Mangold, Aaron R. , Costello, Collin M. , Mangold, A R , Costello, Collin M , Cumsky, Helen J. L., Severson, Kevin J., Mi, Lanyu, DiCaudo, David J., Ochoa, Shari A., Baum, Christian L.

Mayo Clinic

Dermatologic Surgery | September 1, 2021 | Volume: 48 | Issue: 1 | Pages: 12-16

10.1097/dss.0000000000003224 | PMID 34904573 Get It

BACKGROUND Cutaneous squamous cell carcinomas (cSCC) have upstage rates of approximately 10.3% to 11.1%. Data are currently limited on the rate of upstaging for metastatic cSCC. OBJECTIVE The aim of this study was to determine the rates of upstaging, between diagnosis and surgery, and differences in management for metastatic and non-metastatic high-risk cSCC. MATERIALS AND METHODS This was a retrospective, case–control, single institution, multi-center study. Univariate analysis was used. RESULTS Sixty-eight subjects (34 metastatic & 34 non-metastatic) with 69 tumors were included. The overall rate of upstaging was 46.4%. The most common reasons for upstage were undocumented tumor size and under-diagnosis of poor differentiation. There were no differences in rates of upstaging. Preoperative imaging was performed in 43.6% of wide local excisions (WLE) versus 3.3% of Mohs micrographic surgery (MMS; p < .001). The median days from surgery to sentinel lymph node biopsy (SLNB), or nodal dissection was shorter for WLE versus MMS (0 vs 221 days, p < .001). CONCLUSION Improved clinical documentation, including documenting tumor size, and the identification of pathologic risk factors, including poor differentiation and depth of invasion, are needed for proper staging. Preoperative imaging and discussion of SLNB may be beneficial for high-risk T2b and T3 tumors.
CT Noise-Reduction Methods for Lower-Dose Scanning: Strengths and Weaknesses of Iterative Reconstruction Algorithms and New Techniques
Mohammadinejad, Payam , Mileto, Achille , Yu, Lifeng , Leng, Shuai , Guimarães, Luís , Missert, A. , Jensen, Corey T. , Gong, Hao , McCollough, Cynthia H. , Fletcher, Joel G. , Guimaraes, Luis S , Missert, Andrew D , Fletcher, Joel G , McCollough, Cynthia H , Leng, Shuai , Mohammadinejad, Payam , Yu, Lifeng

Mayo Clinic

RadioGraphics | September 1, 2021 | Volume: 41 | Issue: 5 | Pages: 1493-1508

10.1148/rg.2021200196 | PMID 34469209 Get It

Author response: KLF10 integrates circadian timing and sugar signaling to coordinate hepatic metabolism
Gréchez‐Cassiau, Aline, Guérin, Sophie , Martin, Luc , Revel, Johana S., Mehiri, Mohamed, Subramaniam, Malayannan , Ruberto, Anthony A. , Delaunay, Franck , Teboul, Michèle

Mayo Clinic

No container title available | September 1, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.65574.sa2 Get It

Recent Updates in the Treatment of Erythema Multiforme
Soares, Alexa A. , Soares, Alexa , Sokumbi, Olayemi

Mayo Clinic

Medicina | September 1, 2021 | Volume: 57 | Issue: 9 | Pages: 921

10.3390/medicina57090921 | PMID 34577844 Get It

Erythema multiforme (EM) is an immune-mediated condition that classically presents with discrete targetoid lesions and can involve both mucosal and cutaneous sites. While EM is typically preceded by viral infections, most notably herpes simplex virus (HSV), and certain medications, a large portion of cases are due to an unidentifiable cause. EM can be confused with other more serious conditions like Stevens–Johnson syndrome (SJS); however, clinical research has provided significant evidence to classify EM and SJS as separate disorders. Treatment of EM is highly variable, depending on the etiology, the involvement of mucosal sites, and the chronicity (acute vs. recurring) of the disease. If the etiology or causal medication/infection is identified, then the medication is stopped and/or the infection is treated prior to initiating symptomatic treatment. Treatment for acute EM is focused on relieving symptoms with topical steroids or antihistamines. Treatment for recurrent EM is most successful when tailored to individual patients. First line treatment for recurrent EM includes both systemic and topical therapies. Systemic therapies include corticosteroid therapy and antiviral prophylaxis. Topical therapies include high-potency corticosteroids, and antiseptic or anesthetic solutions for mucosal involvement. Second-line therapies for patients who do not respond to antiviral medications include immunosuppressive agents, antibiotics, anthelmintics, and antimalarials